When billed and allowed amounts aren’t enough: HealthVerity proprietary market cost offering in taXonomy
A better way to measure healthcare costs in closed claims data This is the second post in our...
A better way to measure healthcare costs in closed claims data This is the second post in our...
How clinical data linkage closes evidence gaps in real-world data Clinical data linkage helps...
Real World Data (RWD) is increasingly being incorporated into healthcare and life science research...
Healthcare claims data are one of the most powerful sources of data in generating real-world...
Why healthcare marketers need more transparency in audience targeting Healthcare marketers are...
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...
"Healthcare audience targeting has changed fast, and expectations have climbed even faster." As...
AI is rapidly reshaping how real-world data (RWD) is generated and analyzed across healthcare...
Healthcare marketing has reached an inflection point and for years, success was defined by reach:...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically, w...